Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance Study of a New Diagnostic Test for Drug Sensitivity Evaluation in Metastatic Colorectal Cancer

NCT07171554 is registered in ClinicalTrials.gov with Oncosyne AS as lead sponsor.

NCT NCT07171554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07171554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance Study of a New Diagnostic Test for Drug Sensitivity Evaluation in Metastatic Colorectal Cancer
Lead sponsor
Oncosyne AS
Phase
Not applicable
Overall status
Recruiting
Start date
October 28, 2025
Completion date
June 30, 2029
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer (mcrc)